Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/39350
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCUPPENS, Kristof-
dc.contributor.authorBaas, Paul-
dc.date.accessioned2023-01-30T08:54:15Z-
dc.date.available2023-01-30T08:54:15Z-
dc.date.issued2023-
dc.date.submitted2023-01-26T15:42:37Z-
dc.identifier.citationTranslational Lung Cancer Research, 12 (1) , p. 11 -13-
dc.identifier.urihttp://hdl.handle.net/1942/39350-
dc.language.isoen-
dc.publisherAME PUBLISHING COMPANY-
dc.rightsOpen Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the noncommercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.-
dc.subject.otherEarly-stage lung cancer-
dc.subject.otherperioperative strategy-
dc.subject.otherperioperative immune checkpoint inhibition-
dc.subject.otherperioperative targeted therapy-
dc.titleThe path forward in early-stage lung cancer-
dc.typeJournal Contribution-
dc.identifier.epage13-
dc.identifier.issue1-
dc.identifier.spage11-
dc.identifier.volume12-
local.format.pages3-
local.bibliographicCitation.jcatA2-
dc.description.notesBaas, P (corresponding author), Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands.; Baas, P (corresponding author), Leiden Univ, Dept Pulmonol, Med Ctr, Leiden, Netherlands.-
dc.description.notesp.baas@nki.nl-
local.publisher.placeFLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA-
local.type.refereedRefereed-
local.type.specifiedEditorial Material-
dc.identifier.doi10.21037/tlcr-22-546-
dc.identifier.isi000907560600001-
local.provider.typewosris-
local.description.affiliation[Cuppens, Kristof] Jessa Hosp, Dept Pulmonol & Thorac Oncol, Hasselt, Belgium.-
local.description.affiliation[Cuppens, Kristof] Hasselt Univ, Fac Med & Life Sci LCRC, Diepenbeek, Belgium.-
local.description.affiliation[Cuppens, Kristof; Baas, Paul] Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands.-
local.description.affiliation[Baas, Paul] Leiden Univ, Dept Pulmonol, Med Ctr, Leiden, Netherlands.-
local.uhasselt.internationalyes-
item.fullcitationCUPPENS, Kristof & Baas, Paul (2023) The path forward in early-stage lung cancer. In: Translational Lung Cancer Research, 12 (1) , p. 11 -13.-
item.accessRightsOpen Access-
item.fulltextWith Fulltext-
item.contributorCUPPENS, Kristof-
item.contributorBaas, Paul-
crisitem.journal.issn2218-6751-
crisitem.journal.eissn2226-4477-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
The path forward in early-stage lung cancer.pdfPublished version106.77 kBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.